Biotech
Nudge is a neurotechnology company developing non-invasive, MRI-verified focused-ultrasound systems aimed at modulating deep brain circuits implicated in anxiety, OCD, depression, addiction, and chronic pain. Its lead product is a dual-purpose brain imager and stimulator that uses focused ultrasound with imaging-based targeting to modulate defined circuits and measure associated symptom changes. The platform is initially oriented toward conditions with high unmet need and partial treatment resistance, including anxiety, chronic pain, and addiction. However, its broader vision is “to build a headphone-like version [of its product] that could eventually enhance mood, cognition, and overall mental well-being for healthy individuals.”
Building Whole Brain Interfaces for Everyday Life
From Blockchain to Brainwaves: Coinbase Co-Founder Fred Ehrsam Enters the Neurotech Race with Non-Invasive BCI Startup Nudge
About Our Studies
Our Mission, Technology, and Approach
A Comprehensive Review of Low-Intensity Focused Ultrasound Parameters and Applications in Neurologic and Psychiatric Disorders